Discover why Zacks, being the first on Wall Street to initiate coverage of the stock, rates Valhi as "Underperform." Explore how VHI's pricing pressure, weak demand and rising costs could weigh on earnings and limit upside potential.
Valhi (VHI) faces headwinds from lower TiO2 prices and destocking on volumes, pressuring its chemical segment despite a positive perimeter effect from a joint venture buyout. Operating income declined due to falling TiO2 prices, stable input costs and general operating leverage on lower industrial volumes. A higher CAPEX commitment and weak market environment have reduced the NAV discount to just 4%.